Pricing Log in Create free account

Alps Group Inc. (ALPS) vs Kalaris Therapeutics Inc. (KLRS)

Alps Group Inc. and Kalaris Therapeutics Inc. are both Biotechnology companies. Alps Group Inc. and Kalaris Therapeutics Inc. are of similar size ($52.3M and $51.6M). Across the 7 metrics below, Kalaris Therapeutics Inc. leads on 4 and Alps Group Inc. on 3.

Valuation

Metric ALPS KLRS Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B n/m 1.01 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.33 0.66
EV/Sales n/m n/m 9.02
Earnings yield (229.73%) (85.64%) (32.88%)
Free cash flow yield (84.65%) (70.40%) (23.13%)

Profitability

Metric ALPS KLRS Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 25.50% (79.91%) (51.96%)
Return on assets 0.00% (46.02%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALPS KLRS Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 21.95% 94.50% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALPS KLRS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.04 10.98 4.97
Net debt to EBITDA 0.00 2.54 1.01

Dividend

Metric ALPS KLRS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ALPS KLRS Biotechnology median
Market cap 52.30m 51.55m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack